JP2016513724A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513724A5
JP2016513724A5 JP2016502709A JP2016502709A JP2016513724A5 JP 2016513724 A5 JP2016513724 A5 JP 2016513724A5 JP 2016502709 A JP2016502709 A JP 2016502709A JP 2016502709 A JP2016502709 A JP 2016502709A JP 2016513724 A5 JP2016513724 A5 JP 2016513724A5
Authority
JP
Japan
Prior art keywords
matrix
particle size
dosage form
drug
microns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502709A
Other languages
English (en)
Japanese (ja)
Other versions
JP6463333B2 (ja
JP2016513724A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/028125 external-priority patent/WO2014143935A1/en
Publication of JP2016513724A publication Critical patent/JP2016513724A/ja
Publication of JP2016513724A5 publication Critical patent/JP2016513724A5/ja
Application granted granted Critical
Publication of JP6463333B2 publication Critical patent/JP6463333B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502709A 2013-03-15 2014-03-14 オキシカルバゼピンの急速分散性の剤形 Active JP6463333B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361791726P 2013-03-15 2013-03-15
US61/791,726 2013-03-15
PCT/US2014/028125 WO2014143935A1 (en) 2013-03-15 2014-03-14 Rapidly dispersible dosage form of oxcarbazepine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018172088A Division JP2019006812A (ja) 2013-03-15 2018-09-14 オキシカルバゼピンの急速分散性の剤形

Publications (3)

Publication Number Publication Date
JP2016513724A JP2016513724A (ja) 2016-05-16
JP2016513724A5 true JP2016513724A5 (https=) 2017-04-06
JP6463333B2 JP6463333B2 (ja) 2019-01-30

Family

ID=51537567

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016502709A Active JP6463333B2 (ja) 2013-03-15 2014-03-14 オキシカルバゼピンの急速分散性の剤形
JP2018172088A Abandoned JP2019006812A (ja) 2013-03-15 2018-09-14 オキシカルバゼピンの急速分散性の剤形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018172088A Abandoned JP2019006812A (ja) 2013-03-15 2018-09-14 オキシカルバゼピンの急速分散性の剤形

Country Status (10)

Country Link
US (4) US9314429B2 (https=)
EP (1) EP2968354B1 (https=)
JP (2) JP6463333B2 (https=)
CN (1) CN105050604B (https=)
AU (2) AU2014228063B2 (https=)
CA (1) CA2906107C (https=)
ES (1) ES2761265T3 (https=)
HK (1) HK1213472A1 (https=)
MX (1) MX364381B (https=)
WO (1) WO2014143935A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2906029C (en) 2013-03-15 2017-09-05 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
US10716648B2 (en) * 2014-05-02 2020-07-21 University Of Louisville Research Foundation, Inc. Methods for fabricating dental restorations
AU2016272089B2 (en) 2015-06-03 2021-02-18 Triastek, Inc. Dosage forms and use thereof
CN105770899A (zh) * 2016-03-07 2016-07-20 北京诺康达医药科技有限公司 一种大剂量药物的速释制剂及其制备方法
CA3018011A1 (en) * 2016-03-18 2017-09-21 Grunenthal Gmbh Floating pharmaceutical dosage form
US10765658B2 (en) 2016-06-22 2020-09-08 Mastix LLC Oral compositions delivering therapeutically effective amounts of cannabinoids
GB201612853D0 (en) 2016-07-25 2016-09-07 Univ Central Lancashire Solid dosage form production
EP3573602A4 (en) 2017-01-26 2020-09-16 Triastek, Inc. DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES
US10703549B2 (en) * 2017-06-30 2020-07-07 The Procter And Gamble Company Water soluble containers and methods of making them
US20200291347A1 (en) * 2017-10-26 2020-09-17 Merck Patent Gmbh Methods for performing cell culture
CN116270513A (zh) 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
US12544446B2 (en) 2018-03-02 2026-02-10 Vitiprints, LLC Printed delivery device having supplements
JP7614103B2 (ja) 2018-10-15 2025-01-15 アプレシア・ファーマスーティカルズ・エルエルシー 包装内に剤形を形成する方法およびシステム
EP3662898A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Solid composition comprising mesalazine
EP3913243A4 (en) 2019-01-18 2022-10-19 IHI Corporation PRINT FOIL STORE
EP3789015A1 (en) 2019-09-05 2021-03-10 Universität Innsbruck Fast consolidating compounds
ES2828509B2 (es) 2019-11-26 2022-03-09 Fund Idonial Composicion para la impresion 3d de farmacos semisolidos
MX2022012894A (es) * 2020-04-15 2023-01-05 Aprecia Pharmaceuticals LLC Forma de dosificacion empacada de multiples componentes y metodo.
JP2023533478A (ja) * 2020-06-26 2023-08-03 アプレシア・ファーマスーティカルズ・エルエルシー 内部空洞を有する迅速口内分散可能な錠剤
CA3248182A1 (en) 2022-04-13 2023-10-19 Aprecia Pharmaceuticals LLC SYSTEM AND METHOD FOR ADDITIVE MANUFACTURING USING AN OMNIDIRECTIONAL MAGNETIC DISPLACEMENT DEVICE
CN120051272A (zh) * 2022-08-18 2025-05-27 默克专利股份公司 固体药物施用形式的制造方法
WO2024108082A1 (en) 2022-11-18 2024-05-23 Aprecia Pharmaceuticals LLC Orodispersive dosage forms containing droxidopa
FR3162625A1 (fr) * 2024-05-30 2025-12-05 Mb Therapeutics Formulation pharmaceutique imprimable par extrusion, cartouche d’impression renfermant une telle formulation et procédé de préparation d’un médicament la mettant en œuvre

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4642903A (en) 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
US4855326A (en) 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
EP0418596A3 (en) 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5578322A (en) 1990-11-30 1996-11-26 Yamanouchi Pharmaceutical Co., Ltd. Quick release coated preparation
DE4200821A1 (de) 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5380473A (en) 1992-10-23 1995-01-10 Fuisz Technologies Ltd. Process for making shearform matrix
ATE208615T1 (de) 1993-07-09 2001-11-15 Scherer Corp R P Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
US5490962A (en) * 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
CA2134611C (en) 1994-10-28 2002-12-24 Richard John Yarwood Process for preparing solid pharmaceutical dosage forms
US5607697A (en) 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
WO1998036738A1 (en) * 1997-02-20 1998-08-27 Therics, Inc. Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
PL197812B1 (pl) 1999-07-09 2008-04-30 Ortho Mcneil Pharm Inc Doustne ciekłe kompozycje farmaceutyczne maskujące smak
DE19940944B4 (de) 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen
JP5178982B2 (ja) * 2000-05-18 2013-04-10 セリックス， インコーポレイテッド 経口投薬形態における、毒性コアの非毒性領域中へのカプセル化
CA2440069A1 (en) 2001-03-05 2002-09-12 Ortho-Mcneil Pharmaceutical, Inc. Taste masked pharmaceutical compositions
EA200301223A1 (ru) * 2001-05-18 2004-08-26 Рэнбакси Лабораториз Лимитед Лекарственные формы окскарбазепина
EP1439824A2 (en) * 2001-10-29 2004-07-28 Therics, Inc. Three-dimensional suspension printing of dosage forms
EP1536774A1 (en) 2002-09-04 2005-06-08 Ranbaxy Laboratories Limited Taste masked dosage forms and processes for their preparation
WO2004052345A1 (en) 2002-12-11 2004-06-24 Ranbaxy Laboratories Limited Coating composition for taste masking coating and methods for their application and use
JP4739217B2 (ja) 2003-05-07 2011-08-03 サムヤン コーポレイション 速く溶ける錠剤を製造するための高可塑性顆粒
FR2858556B1 (fr) 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
US20070154550A1 (en) 2003-08-28 2007-07-05 Potdar Arti Pharmaceutical composition comprising anticonvulsant with taste mask coating
US20060127479A1 (en) 2004-10-08 2006-06-15 Natrajan Kumaraperumal Solvent free taste masked pharmaceutical compositions
WO2006070406A1 (en) * 2004-12-29 2006-07-06 J.B. Chemicals & Pharmaceuticals Ltd Bilayer tablets of oxcarbazepine for controlled delivery and a process of preparation thereof
US20060182796A1 (en) 2005-02-03 2006-08-17 Abrika Pharmaceuticals, Inc. Taste masked pharmaceutical compositions
US20070092553A1 (en) 2005-10-21 2007-04-26 Pfab Lp Compositions and methods of making rapidly dissolving lonically masked formulations
CA2630240A1 (en) * 2006-01-31 2007-08-09 Teva Pharmaceutical Industries Ltd. Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
US20070248684A1 (en) * 2006-01-31 2007-10-25 Sigal Blau Pharmaceutical formulations of oxcarbazepine and methods for its preparation
WO2007089926A2 (en) * 2006-01-31 2007-08-09 Teva Pharmaceutical Industries Ltd. Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
EP2010499A4 (en) * 2006-04-21 2012-07-18 Alphapharm Pty Ltd PHARMACEUTICAL COMPOSITION OF OXCARBAZEPINE PARTICULATE FROM 15 TO 30 MICRONS IN AVERAGE
EP2146699A2 (en) * 2007-05-23 2010-01-27 Ratiopharm GmbH Pharmaceutical compositions comprising oxcarbazepine
JP5637624B2 (ja) 2009-02-12 2014-12-10 富士化学工業株式会社 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物
US20100285130A1 (en) 2009-05-06 2010-11-11 Monosol Rx, Llc Coating of complexed actives in film formulations
US20120076858A1 (en) 2009-06-04 2012-03-29 Basf Se Orally Disintegrating Dosage Forms Containing Taste-Masked Active Ingredients
US20120207836A1 (en) 2009-08-19 2012-08-16 Bayer Pharma Aktiengesellschaft Drug delivery systems (wafer) for pediatric use
US20110212171A1 (en) 2010-01-08 2011-09-01 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
US9381154B2 (en) * 2011-06-09 2016-07-05 Xerox Corporation Direct inkjet fabrication of drug delivery devices

Similar Documents

Publication Publication Date Title
JP2016513724A5 (https=)
WO2014143935A4 (en) Rapidly dispersible dosage form of oxcarbazepine
JP5911927B2 (ja) 併用治療のための錠剤
JP2016514680A5 (https=)
JP2016514686A5 (https=)
KR20190107712A (ko) 특정 위장 부위에서의 제어 방출의 투여 형태
KR102046248B1 (ko) 다공성 위체류층을 포함하는 서방성 제제 및 이의 제조방법
JP2015511635A5 (https=)
WO2012164578A1 (en) Compositions and methods for preparing immediate release formulations of nilotinib
WO2010020856A3 (en) Rate modulated delivery of drugs from a composite delivery system
HRP20240045T1 (hr) Tablete s trenutnim oslobađanjem koje sadrže lijek i postupci za proizvodnju tableta
HRP20190550T1 (hr) Formule i metode proizvodnje formulacija za upotrebu u pražnjenju debelog crijeva
Ganesh et al. In vitro evaluation of the effect of combination of hydrophilic and hydrophobic polymers on controlled release zidovudine matrix tablets
JP2015120758A5 (https=)
Aslam et al. Techniques and polymers used to design Gastroretentive drug delivery systems–a review
JP5347092B2 (ja) アンドログラフィス抽出物製剤
Purushothaman et al. Formulation development and Evaluation of immediate and sustained release Bilayer Tablets Containing Amitriptyline HCl and Pregabalin for the treatment of Neuropathic Pain
RU2662562C2 (ru) Композиция в форме таблеток, содержащая гидрохлорид цинакалцета
JP2017520619A5 (https=)
CN108289849A (zh) 莫沙必利与雷贝拉唑的复合制剂
Khemariya et al. Preparation and in-vitro evaluation of sustained-release matrix tablets of Diltiazem
WO2005082329A2 (en) Process for the preparation of solid dosage forms of valsartan and hydrochlorthiazide
EP3496719A1 (en) A multi-class anti-retroviral composition
JP2018530538A5 (https=)
JP5910311B2 (ja) 医薬錠剤およびその製造方法